Sentences with phrase «availability of funds from»

In addition, the lack of buyers for upper priced homes and the limited availability of funds from banks has resulted in lackluster sales in the upper price ranges.

The commissioner shall, from time to time and subject to the availability of funds from the Homeless Animal Prevention and Care Fund in section 35WW of chapter 10, provide for a training course for animal control officers.

Our policy is to delay the availability of funds from your cash and check deposits.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, and capital markets conditions and other factors beyond the Company's control, including natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) the Company's credit ratings and its cost of capital; (3) competitive conditions and customer preferences; (4) foreign currency exchange rates and fluctuations in those rates; (5) the timing and market acceptance of new product offerings; (6) the availability and cost of purchased components, compounds, raw materials and energy (including oil and natural gas and their derivatives) due to shortages, increased demand or supply interruptions (including those caused by natural and other disasters and other events); (7) the impact of acquisitions, strategic alliances, divestitures, and other unusual events resulting from portfolio management actions and other evolving business strategies, and possible organizational restructuring; (8) generating fewer productivity improvements than estimated; (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; and (11) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report on Form 10 - K for the year ended Dec. 31, 2017, and any subsequent quarterly reports on Form 10 - Q (the «Reports»).

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

In addition to factors previously disclosed in Tesla's and SolarCity's reports filed with the U.S. Securities and Exchange Commission (the «SEC») and those identified elsewhere in this document, the following factors, among others, could cause actual results to differ materially from forward - looking statements and historical performance: the ability to obtain regulatory approvals and meet other closing conditions to the transaction, including requisite approval by Tesla and SolarCity stockholders, on a timely basis or at all; delay in closing the transaction; the ultimate outcome and results of integrating the operations of Tesla and SolarCity and the ultimate ability to realize synergies and other benefits; business disruption following the transaction; the availability and access, in general, of funds to meet debt obligations and to fund ongoing operations and necessary capital expenditures; and the ability to comply with all covenants in the indentures and credit facilities of Tesla and SolarCity, any violation of which, if not cured in a timely manner, could trigger a default of other obligations under cross-default provisions.

Such risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including with respect to the Merger; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions and / or guaranty fund assessments; uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific risks and uncertainties discussed in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.express-scripts.com.

A similar invasion of civil rights is implicit in the initiative to require doctors to report to the Department of Health persons infected with the AIDS virus, and in the proposed restrictions that would prohibit any family planning institution receiving federal funds from informing clients of the availability of abortion services.

The added competition for retail funds from NS&I not only distorts the savings market, but increases the cost and reduces the availability of mortgage funding which building societies and other lenders rely on for mortgage lending.

The Erie County Department of Environment and Planning is announcing the availability of $ 350,000 in federal funding from the HOME Investment Partnership Program (HOME).

Collins and Perez didn't mention, however, where the new money will come from or how or whether the change will affect the availability of NIH funds for other purposes, such as research grants.

(2) the authorization or availability of appropriations from the Funds shall be treated as new direct spending and attributed to this Act.

The conditions were ideal for this groundbreaking shift: a citywide consensus that the old system had failed; a once - in - a-lifetime opportunity to build a new system from scratch; the availability of federal school start - up funds; and the keen interest of education entrepreneurs, foundations, and support organizations in seeing this bold reform succeed.

The organization, which was funded by a grant from the U.S. Department of Education, provided critical information to parents about quality school options and the availability of free after - school tutoring services.

WASHINGTON - U.S. Transportation Secretary Anthony Foxx today announced the immediate availability of $ 750,000 in emergency relief funds from the U.S. Department of Transportation to help the Michigan Department of Transportation cover the costs of repairing roads and bridges damaged by rainfall in the Detroit metro area.

Pursuant to the recently enacted Fixing America's Surface Transportation Act (FAST Act), DOT announced the availability of $ 1.435 billion in capital over five years for the TIFIA credit assistance program (and any funds that may be available from prior fiscal years) to provide TIFIA credit assistance for eligible projects.

WASHINGTON - U.S. Transportation Secretary Anthony Foxx today announced the immediate availability of $ 750,000 in emergency relief funds from the Federal Highway Administration (FHWA) to help Iowa cover the costs of repairing roads damaged by flooding earlier this week.

WASHINGTON — U.S. Transportation Secretary Anthony Foxx today announced the immediate availability of $ 1 million in Emergency Relief (ER) funds from the Federal Highway Administration (FHWA) to help begin repairs on flood - damaged roads and bridges in north and central Pennsylvania.

WASHINGTON - U.S. Transportation Secretary Anthony Foxx today announced the immediate availability of $ 1 million in emergency relief funds from the U.S. Department of Transportation to help the Tennessee Department of Transportation cover the costs of repairing the I - 65 bridge over Peytonsville Road, located in the city of Franklin south of Nashville, which was damaged by a truck fire.

The Federal Transit Administration (FTA) announces the availability of approximately $ 5 million in funding from the Fiscal Year 2017 Public Transportation on Indian Reservations Program (Tribal Transit Program or TTP), contingent on Congressional appropriation.

WASHINGTON — U.S. Transportation Secretary Anthony Foxx today announced the immediate availability of $ 2 million in Emergency Relief (ER) funds from the Federal Highway Administration (FHWA) to stabilize and repair roads damaged by heavy rains on federal lands throughout Idaho, Oregon, and Washington.

Managed resources in an organization may differ from the availability of funding, human resources, technical resources and natural resources and this will be different challenging assignments for the business aspects where our team can help you.

The availability of income from other sources, such as savings, pensions, mutual funds, or annuities, can affect someone's claiming strategy, too.

Remote Deposit Capture expedites funds availability by depositing checks from multiple locations and taking advantage of longer deposit times.

By indicating your acceptance of these Terms and Conditions, the Privacy Notice, and the Electronic Communication Disclosure (collectively, the «Agreement») and by establishing, using, or continuing to have an Account, you agree to be bound by the terms and conditions contained in the Agreement, as may be amended from time to time, including but not exclusive to the Arbitration and Funds Availability provisions in these Terms and Conditions.

Brokers are graded here on their webpage for trading stocks, bonds and funds; on the range of investment products clients can buy online; and the availability of registered accounts that can hold U.S. dollars (many brokers force a conversion into Canadian dollars when clients sell U.S. stocks or receive dividends from such stocks).

These Terms and Conditions are supplemental to, and do not supersede or replace, any agreement with us pertaining to (a) the Account (including, but not limited to, Your Deposit Terms and Conditions, Account Information Statement, Funds Availability Disclosure and Electronic Funds Transfer Services, all as may be amended or restated from time to time); (b) any BancorpSouth checking or savings account which is a Source (including, but not limited to, Your Deposit Terms and Conditions, Account Information Statement, Funds Availability Disclosure and Electronic Funds Transfer Services, all as may be amended or restated from time to time); (c) any BancorpSouth line of credit which is a Source (including, but not limited to, the promissory note or other credit agreement which is applicable to the line of credit and the security agreements, if any, which secure payment of the line of credit); and (d) any BancorpSouth credit card which is a Source (including, but not limited to, the cardholder agreement which is applicable to the credit card as may be amended or restated from time to time).

There may be a two - hour delay from filing time of new fund names to viewing availability.

The law states: «Each animal control officer shall, within 24 months of the effective date of this act if serving as an animal control officer before the effective date of this act or within 12 months from the officer's date of hire if such date of hire is on or after the effective date of this act, complete a training course offered under section 151C of chapter 140 of the General Laws; provided, however, that such training requirement shall be subject to the availability of funds in the Homeless Animal Prevention and Care Fund, established in section 35TT of chapter 10 of the General Laws, as determined by the commissioner of the department of agricultural resources.

Congressional approval of this funding in the 2005 Energy Policy Act may forbid resulting projects from being considered by EPA as proof of demonstrated availability.

Lisa Guelfi, a Partner in the social housing development team at Clarke Willmott, said: «Key issues for housing associations, such as availability of grant funding, rent review restrictions which are limiting the number of affordable rented properties being provided, and the question of what will happen with Right to Buy receipts from the Midlands pilot and beyond, aren't really addressed.

Collaborative efforts stemming from our February 11, 2016 Access to Justice BC Leadership Group meeting resulted in Access to Justice BC working alongside the Mediate BC Family Unbundled Legal Services Project (funded by the Law Foundation) to support and promote the availability of «unbundled» legal services.

There were three aspects to such agreements: (i) a CFA between the claimant and a solicitor; (ii) the availability of a loan from a funder to cover the claimant's disbursements and other costs; and (iii) insurance to cover the claimant for his own disbursements, the defendant's costs, the insurance premium and the loan interest should the claim fail.

Common Features of Kotak Mahindra Old Mutual Life Investment Plans: A variety of Investment Strategies to choose from Option of choosing from a range of funds as per your risk appetite Liberty to switch between funds Facility of Premium Redirection Provision of making partial withdrawals Availability of three settlement options at maturity Income tax benefits

Moneys received from the mandatory civil penalties imposed pursuant to this subsection upon persons required to appear before a designated official pursuant to s. 318.19 (1) or (2) shall be remitted to the Department of Revenue and deposited into the Department of Health Emergency Medical Services Trust Fund to provide financial support to certified trauma centers to assure the availability and accessibility of trauma services throughout the state.

Respond Software emerged from stealth on Aug. 16 debuting the general availability of its Respond Analyst platform along with $ 12 million in Series A funding.

The Senate passed a $ 1.1 billion deal in June, but the House's approval of its own $ 1.1 billion in funding was filibustered by Democrats, who argued that they were left out of negotiations on the bill and that the measure would take funds away from other health programs and bar any availability of funds for birth control.

We are writing in response to your inquiry for updated data on the availability of contraceptive care from safety - net family planning centers in the United States, particularly the role of Planned Parenthood in meeting women's need for publicly funded contraceptive care.

In order to respond, we have expanded upon the analysis that we conducted in response to your April 7, 2017 request for information concerning the availability of publicly funded contraceptive care to U.S. women, particularly from sites operated by Planned Parenthood and federally qualified health centers (FQHCs).1 In this analysis, we assume that all the clients seeking contraceptive care who are currently served by Planned Parenthood health centers in each state would be distributed to other types of safety - net family planning centers in the same proportions that contraceptive clients are currently served by each of these other types of centers.

In a previous column I discussed how money from overseas is having a powerful impact on the availability of funding for new development here in the U.S., and is extending the nation's economic recovery.